Exactus, Inc., is a healthcare company pursuing opportunities in hemp derived Cannabidiol (CBD) products. The company sells its CBD products through its Exactus brand and white label products to third-party resellers. Exactus is also engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities.
On January 8, 2019 Exactus entered into a Master Product Development and Supply Agreement with Ceed2Med. Ceed2Med utilizes cGMP facilities and has the Under the Agreement, Exactus has been allotted a minimum of 50 and up to 300 kilograms per month, and up to 2,500 kilograms annually, of active phyto-cannabinoid (CBD) rich ingredients for resale. The company offers tinctures, edibles, capsules, and topical solution products manufactured for use by Ceed2Med.
Exactus One World
Exactus One World is the name of the Exactus farming and production initiative because it captures the expansive and inclusive nature of the vision of a comprehensive seed to sale consumer program. The seeds (genetics) used at Exactus One World are sourced from Oregon CBD, founded by Seth and Eric Crawford, who are believed to have developed superior strains of hemp seeds and are thought to be one of the world's leading breeding, research and production facilities for CBD seed. Exactus farms and processes industrial hemp to be manufactured into cannabidiol (CBD) related products using, as much as possible, their facilities and cGMP resources at every step of the supply chain.
Our leadership team includes technical experts and business leaders with a proven track record of increasing shareholder value and developing and launching new products.
Get in Touch
At Exactus, Inc. we believe there are significant market opportunities for our CBD products. Contact us with questions about our company, our products and possible partnership opportunities.